Canada markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.71-0.08 (-0.31%)
At close: 04:00PM EDT
25.71 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-76,831
-82,667
-14,859
4,134
-23,982
-
Depreciation & amortization
12,729
14,217
14,487
14,317
13,464
-
Deferred income taxes
-3,761
-6,327
-5,270
-1,766
-3,543
-
Stock based compensation
15,116
15,243
14,315
11,085
5,386
-
Change in working capital
-16,944
-12,123
-11,821
-14,718
-13,458
-
Accounts receivable
-1,738
-1,305
-5,630
-6,216
5,855
-
Inventory
-12,423
-11,396
-6,873
-6,619
-14,177
-
Accounts Payable
1,103
-11
1,965
-1,100
822
-
Other working capital
-4,142
-7,215
-3,077
3,254
11,437
-
Other non-cash items
2,254
2,231
1,850
-12,940
-16,065
-
Net cash provided by operating activites
1,704
-1,788
4,409
8,397
13,065
-
Cash flows from investing activities
Investments in property, plant and equipment
-5,846
-5,427
-7,486
-5,143
-1,628
-
Acquisitions, net
-
0
0
-476
-94,601
-
Purchases of investments
-
-
0
0
-20,035
-103,848
Sales/Maturities of investments
-
0
0
2,501
45,000
-
Net cash used for investing activites
-5,846
-5,427
-7,486
-3,118
-71,264
-
Cash flows from financing activities
Debt repayment
-
0
-284
-201
-50,558
-
Common stock repurchased
-
-5,000
0
0
0
-
Other financing activites
-2,828
-2,152
-5,249
-7,706
-4,740
-
Net cash used privided by (used for) financing activities
-6,984
-6,324
-4,852
-6,779
-3,774
-
Net change in cash
-11,108
-13,460
-8,059
-1,431
-61,646
-
Cash at beginning of period
79,737
86,327
94,386
95,817
157,463
-
Cash at end of period
68,611
72,867
86,327
94,386
95,817
-
Free Cash Flow
Operating Cash Flow
1,704
-1,788
4,409
8,397
13,065
-
Capital Expenditure
-5,846
-5,427
-7,486
-5,143
-1,628
-
Free Cash Flow
-4,142
-7,215
-3,077
3,254
11,437
-